Marilyn Frances Velez, ARNP

Marilyn Velez practices at Institute of Endocrinology Diabetes Health and Hormones in Kissimmee, Florida.

Marilyn Velez's NPI, 1861877839, was assigned on July 20, 2015. Marilyn Velez holds Florida license ARNP9245495.

Marilyn Velez's primary practice is Institute of Endocrinology Diabetes Health and Hormones, at 204 W Oak St, Kissimmee, FL 34741 in Osceola County. The practice phone is (850) 522-5490.

Marilyn Velez's primary practice is Institute of Endocrinology Diabetes Health and Hormones in Kissimmee, Florida. Marilyn Velez is also affiliated with HCA Florida Osceola Hospital. The medical group on file is Institute of Endocrinology Diabetes, Health & Hormones. Dmand AI also links Marilyn Velez to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Marilyn Velez practices, 6 sites in all. Vendor and product names are available with a free account.

Family is Marilyn Velez's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Marilyn Velez is licensed in Florida.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, insomnia, pneumonia and pulmonary fibrosis among the conditions Marilyn Velez treats.

CMS data shows 80 Medicare services from Marilyn Velez across 3 procedure codes in 2024, for 60 Medicare patients. Medicare paid $5,805 for them.

CMS counts 60 Medicare patients who saw Marilyn Velez in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have diabetes, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Marilyn Velez's median patient age at 52, with 66% women.

In 2024, Marilyn Velez wrote 504 Medicare Part D claims for 168 patients. 32% of them were for generic drugs. CMS names the drug for 284 of them, across 13 drugs with 11 or more claims each, at $374,506 in total drug cost.

Marilyn Velez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Marilyn Velez as offering telehealth.

CMS Open Payments shows 128 general payments to Marilyn Velez from 29 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $367.